You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Neurological conditions
  5. Epilepsy

Cannabidiol for treating seizures caused by tuberous sclerosis complex

  • Technology appraisal guidance
  • Reference number: TA873
  • Published:  01 March 2023

Register as a stakeholder

  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

On this page

  1. Expected publication
  2. Final draft guidance
  3. Draft guidance: 1
  4. Invitation to participate
  5. Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators

History

A list of downloadable documents created during development.

Expected publication

  • Final appraisal document (PDF 308 KB)

    Published:
    31 January 2023
  • Committee papers (PowerPoint 2.62 MB)

    Published:
    31 January 2023

Final draft guidance

  • Final draft guidance

Draft guidance: 1

  • Draft guidance: 1

  • Appraisal consultation document (online commenting)

  • Appraisal consultation document (PDF version) (PDF 292 KB)

    Published:
    08 November 2022
  • Committee papers (PDF 3.69 MB)

    Published:
    08 November 2022
  • Public committee slides (PDF 2.24 MB)

    Published:
    08 November 2022

Invitation to participate

  • Final scope (PDF 170 KB)

    Published:
    18 January 2022
  • Final stakeholder list (PDF 201 KB)

    Published:
    18 January 2022
  • NICE's response to comments on the draft scope and provisional stakeholder list (PDF 227 KB)

    Published:
    18 January 2022
  • Equality impact assessment (Scoping) (PDF 126 KB)

    Published:
    18 January 2022

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators

  • Draft scope post referral (PDF 176 KB)

    Published:
    19 April 2021
  • Draft matrix post referral (PDF 186 KB)

    Published:
    19 April 2021
Back to top